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ABSTRACT
Synthetic RNA control devices that use ribozymes
as gene-regulatory components have been applied
to controlling cellular behaviors in response to en-
vironmental signals. Quantitative measurement of
the in vitro cleavage rate constants associated
with ribozyme-based devices is essential for
advancing the molecular design and optimization
of this class of gene-regulatory devices. One of the
key challenges encountered in ribozyme character-
ization is the efficient generation of full-length RNA
from in vitro transcription reactions, where condi-
tions generally lead to significant ribozyme
cleavage. Current methods for generating full-
length ribozyme-encoding RNA rely on a trans-
blocking strategy, which requires a laborious gel
separation and extraction step. Here, we develop a
simple two-step gel-free process including cis-
blocking and trans-activation steps to support
scalable generation of functional full-length
ribozyme-encoding RNA. We demonstrate our
strategy on various types of natural ribozymes and
synthetic ribozyme devices, and the cleavage rate
constants obtained for the RNA generated from
our strategy are comparable with those generated
through traditional methods. We further develop a
rapid, label-free ribozyme cleavage assay based
on surface plasmon resonance, which allows con-
tinuous, real-time monitoring of ribozyme cleavage.
The surface plasmon resonance-based character-
ization assay will complement the versatile cis-
blocking and trans-activation strategy to broadly
advance our ability to characterize and engineer
ribozyme-based devices.
INTRODUCTION
Synthetic biology is advancing the design of genetic circuits
encoding desired functions (1). As the proper functioning
of synthetic genetic circuits often relies on the precise
control and tuning of key protein component levels,
much effort in the ﬁeld has focused on developing pro-
grammable gene-regulatory devices. One class of gene-
regulatory device, so called RNA control devices, uses
RNA molecules to link changes in molecular signals to
gene expression events. Progress in the ﬁelds of RNA
biology and engineering have allowed construction of
RNA control devices through the assembly of natural or
synthetic components that encode more basic functions,
such as sensing, information transmission and actuation
(2). Because ribozymes can exhibit activity independent
of cell-speciﬁc machinery, RNA control devices that use
ribozyme-based actuator components have been demon-
strated in diverse organisms, spanning bacterial, yeast
and mammalian systems, to regulate cellular behaviors in
response to one or more environmental signals (3–6).
We recently described a modular ribozyme device
platform based on the functional coupling of three
distinct components: an actuator encoded by a hammer-
head ribozyme (HHRz) from satellite RNA of tobacco
ringspot virus (sTRSV), a sensor encoded by an RNA
aptamer and an information transmitter encoded by a
sequence capable of a programmed strand-displacement
event (3) (Figure 1). The transmitter component directs
the device to partition between two primary functional
conformations, where the aptamer-folded conformation
can bind the cognate ligand and be associated with the
disruption or restoration of the ribozyme catalytic core
to construct devices that increase or decrease gene expres-
sion, respectively, in response to input ligand. For
example, synthetic ribozyme devices that respond to theo-
phylline have been designed and used for various cellular
engineering applications (3,4). The quantitative tuning
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of the dynamic range of the regulatory device, which is
determined by the gene-expression levels in the absence
and presence of input ligand, has been demonstrated to
be important for achieving effective control over pheno-
typic behaviors (4). Computational models of ribozyme
devices have predicted that the ribozyme cleavage rate
constant can have substantial impact on the gene-
regulatory activities exhibited by a given device (7).
Therefore, methods that allow the quantitative measure-
ment of ribozyme cleavage rate constants of many sets of
engineered RNA devices are essential to advance our
understanding of the relationship between the in vitro
cleavage rate constants and the corresponding in vivo
gene-regulatory activities.
A key challenge in characterizing ribozyme cleavage rate
constants is in the efﬁcient generation of full-length RNA
for ribozyme constructs, including natural ribozymes and
synthetic ribozyme devices, by in vitro transcription.
Typical transcription reactions require high MgCl2 concen-
trations (mM) to achieve sufﬁcient yield, conditions at
which most ribozyme constructs exhibit high cleavage
activity, thereby resulting in low yield of full-length RNA
for the subsequent kinetic analysis. In earlier approaches,
researchers addressed this challenge by splitting the
ribozyme sequence into enzyme and substrate strands
such that the two strands were transcribed separately and
annealed to generate a discontinuous ribozyme duplex
(8–10). However, this strategy requires careful optimization
of the experimental conditions to ensure that the measured
cleavage rate constant is not affected by the association step
between the two strands (11). More recently, researchers
implemented a trans-blocking strategy to generate continu-
ous ribozyme transcripts by including an antisense DNA
oligonucleotide complementary to the ribozyme catalytic
core in the transcription reactions to inhibit formation of
the active structure. Full-length trans-blocked RNA is sub-
sequently isolated through polyacrylamide gel electrophor-
esis (PAGE) under denaturing conditions, and the
recovered RNA is renatured before performing the
cleavage assay (8,12). Studies have shown that 30% of
the gel-puriﬁed full-length RNA is capable of cleaving
during sample handling before initiating the cleavage
assays, and 50% of the remaining full-length RNA does
not exhibit cleavage activity, where the loss of activity has
been attributed to RNA misfolding (8). Therefore, a more
efﬁcient strategy to generate full-length ribozyme-encoding
RNA is desired.
Ribozyme cleavage rate constants are typically
measured through a gel electrophoretic separation
method, which is convenient for detecting nucleic acids
of different sizes (11,12). The cleavage reaction is initiated
by the addition of MgCl2 to radiolabeled full-length RNA
and quenched at different time points. The cleaved and
uncleaved strands in the quenched samples are resolved
by denaturing PAGE to determine the fraction of RNA
cleaved as a function of time, which are ﬁt to a ﬁrst-order
exponential equation to ultimately obtain the cleavage
rate constant. Because the gel-based ribozyme cleavage
Figure 1. Modular composition and mechanism of a synthetic ligand-responsive ribozyme device. The ribozyme device is constructed by linking a
RNA aptamer (indicated in grey) to a HHRz (indicated in white) through a transmitter sequence (indicated in black) that directs a
strand-displacement event. The device can adopt two primary functional conformations, in which the ribozyme-active conformation is associated
with either an aptamer-unformed or -formed conformation to construct a ribozyme device that upregulates or downregulates gene expression,
respectively, in response to input ligand. The device depicted here favors the formation of the ribozyme-active conformation in the absence of
the input ligand, thereby leading to self-cleavage and decreased gene expression. In the presence of the input ligand, binding of the ligand to the
aptamer-formed conformation (i.e. ribozyme-inactive conformation) shifts the distribution to favor this conformation, resulting in no cleavage and
increased gene expression. The arrow indicates the location of the cleavage site. All secondary structures were predicted by RNAstructure folding
software (32) and rendered using VARNA software (33).
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assay is discontinuous, several time points are required in
the initial and ﬁnal phases of the reaction for proper
analysis, thereby making the gel-based assay a time-
consuming process. A continuous ribozyme cleavage
assay based on the intramolecular ﬂuorescence resonance
energy transfer has been developed and applied to char-
acterize ribozyme cleavage rate constants (13,14).
However, the ﬂuorescence resonance energy transfer-
based cleavage assay requires labeling of RNA molecules
with appropriate ﬂuorophores and has only been applied
to the characterization of discontinuous ribozyme
duplexes.
Advances in biosensor technologies have led to the devel-
opment of the Biacore platform based on surface plasmon
resonance (SPR) for real-time detection of biomolecular
interactions (15). The Biacore platform uses a sensor
surface modiﬁed with one molecule and measures the re-
fractive index change, which is associated with the local
mass density change, owing to the association or dissoci-
ation of another molecule in solution. The refractive index
change is converted into a SPR signal, which is expressed in
resonance units (RU), and ﬁt to a mathematical model to
acquire thermodynamic and kinetic binding parameters.
The Biacore platform requires no labeling of molecules,
consumes little sample and is highly automated, thus
making it an attractive tool for developing novel ribozyme
characterization strategies.
In this work, we developed a simple gel-free strategy that
allows efﬁcient generation of full-length RNA sequences
for diverse ribozyme constructs. Our strategy is inspired
by an earlier structural study of the natural hepatitis
delta virus (HDV) ribozyme (16). In the HDV RNA
genome, the sequence immediately upstream of the HDV
ribozyme cleavage site inhibits cleavage by hybridizing to
part of the ribozyme, and the cleavage activity of the in-
hibited HDV ribozyme is rescued by the addition of a syn-
thetic antisense oligomer, which sequesters the natural
cis-blocking sequence through hybridization. We de-
veloped a similar two-step process, which can be adapted
to different ribozymes. In the ﬁrst blocking step, we
designed an RNA sequence that was directly incorporated
into the target transcript to co-transcriptionally inhibit the
formation of the ribozyme-active conformations. In the
second activation step, we designed a trans-acting DNA
competing strand to restore the catalytic activity of
the blocked RNA through a rapid toehold-mediated
strand-displacement reaction. We demonstrated our two-
step strategy to generate functional continuous RNA
sequences for various types of natural ribozymes and syn-
thetic ribozyme devices and observed high blocking and
activation efﬁciencies up to97% and89%, respectively.
The results from gel-based ribozyme cleavage assays
validate that the RNA generated through our two-step
strategy exhibit similar kinetics as those generated
through traditional trans-blocking methods. Lastly, we
developed a label-free, real-time, continuous SPR-based
ribozyme cleavage assay. Our results suggest that the
SPR-based cleavage assay can provide a rapid assessment
of ribozyme cleavage activity under varying reaction con-
ditions, thereby providing a powerful tool for complement-
ing the traditional gel-based assay method.
MATERIALS AND METHODS
Preparation of DNA templates for T7 transcription
reaction
DNA synthesis was performed by Integrated DNA
Technologies (Coralville, IA) or the Protein and Nucleic
Acid Facility (Stanford, CA). PCR products were used as
the DNA templates for in vitro T7 transcription reactions.
For the cis-blocked ribozyme constructs, PCR products
were ampliﬁed from DNA templates using the forward
primer T7-fwd (50-TTCTAATACGACTCACTATAGG)
and the corresponding reverse primer, which is speciﬁc to
each construct (Supplementary Table S1).
Generation of full-length RNA through the
cis-blocking strategy
A total of 1–2 mg of PCR product was transcribed in a
25 ml reaction, consisting of the following components:
1 RNA Pol Reaction Buffer (New England Biolabs,
Ipswich, MA), 2.5mM of each rNTP, 1 ml RNaseOUT
(Invitrogen, Carlsbad, CA), 10mM MgCl2, 1 ml T7 RNA
Polymerase (New England Biolabs) and 0.5 mCi
a-32P-GTP (MP Biomedicals, Solon, OH). The RNA con-
centration was estimated by performing a parallel cold
(without radioactivity) transcription reaction. After incu-
bation at 37C for 2 h, NucAway Spin Columns (Ambion,
Austin, TX) were used to remove unincorporated nucleo-
tides from the transcription reactions according to manu-
facturer’s instructions. The transcription products were
puriﬁed with the RNA Clean and ConcentratorTM-5
(Zymo Research, Irvine, CA) kit according to manufac-
turer’s instructions.
Gel-based ribozyme cleavage assays
All gel-based ribozyme cleavage assays were performed in
a physiologically relevant reaction buffer (50 ml) composed
of 500 mM MgCl2, 100mM NaCl and 50mM Tris-HCl
(pH 7.5) at 37C unless otherwise speciﬁed. In the
reaction volume, 75 nM of full-length RNA generated
from the cis-blocking strategy was ﬁrst incubated with
2.5mM DNA activator strand (50-AAACAACTTTGTTT
GTTTCCCCC), which is ordered from Integrated DNA
Technologies as an oligonucleotide with standard desalt-
ing, for 2min to activate the blocked RNA. Full-length
RNA generated from the trans-blocking strategy was
incubated at 95C for 5min, cooled at a rate of 1.3C/
min to 37C, and held at 37C for 10min to allow equili-
bration of secondary structure. A zero time-point aliquot
was taken before initiating the self-cleavage reaction with
the addition of MgCl2. Reactions were quenched at
speciﬁed time points with addition of 3 volumes of RNA
stop/load buffer (95% formamide, 30mM EDTA, 0.25%
bromophenol blue, 0.25% xylene cyanol) on ice. Samples
were heated to 95C for 5min, snap cooled on ice for 5
min and size-fractionated on a denaturing (8.3M Urea)
10% polyacrylamide gel at 25W for 45–60min. Gels were
exposed overnight on a phosphor screen and imaged on a
FX Molecular Imager (Bio-Rad, Hercules, CA). The
relative levels of the full-length transcript and cleaved
products were determined by phosphorimaging analysis.
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The blocking and activation efﬁciencies of the cis-blocked
ribozyme constructs were determined by the fractions of
the uncleaved RNA after the transcription reaction and
the fractions of the cleaved blocked RNA at the end of
incubation with DNA activator and MgCl2, respectively.
To determine cleavage rate constants, the cleaved product
fraction at each time point (Ft) was ﬁt to the single expo-
nential equation Ft=F0+(F1F0) (1 – ekt) using
Prism 5 (GraphPad), where F0 and F1 are the fractions
cleaved before the start of the reaction and at the reaction
endpoint, respectively, and k is the ﬁrst-order rate
constant of self-cleavage. All reported cleavage rate con-
stants are the mean of at least three independent
experiments.
Biacore sensor chip surface generation
Biosensor experiments were performed on a Biacore X100
instrument (Biacore, Uppsala, Sweden). A CM5 sensor
chip (Biacore) was docked in the Biacore X100 and
equilibrated with HBS-N buffer at 25C. The DNA activa-
tor strand (50-AAACAACTTTGTTTGTTTCCCCC-/
AmMO/), with an amino modiﬁcation on its 30 end,
was immobilized to the chip surface via standard
amine-coupling chemistry. Brieﬂy, the carboxymethyl
surface of the CM5 chip was activated for 7min at a ﬂow
rate of 5 ml/min using a 1:1 volume ratio of 0.4M 1-ethyl-3-
(3-dimethylaminopropyl) carbodiimide (Biacore) and
0.1M N-hydroxysuccinimide (Biacore). A molar ratio of
1:60 of DNA activator to cetyl trimethylammonium
bromide (Amresco, Solon, OH) was diluted in 10mM
HEPES buffer (Sigma, St. Louis, MO) to a ﬁnal concen-
tration of 10 mM and 0.6mM, respectively, and injected
over the activated surface for 10min at a ﬂow rate of
5 ml/min. Excess activated groups were blocked by an in-
jection of 1M ethanolamine (Biacore), pH 8.5, for 7min
at a ﬂow rate of 5 ml/min. The immobilization reaction
was performed on both ﬂow cells (FC1, FC2), where FC1
was used as a reference cell to correct for bulk refractive
index changes, matrix effects, non-speciEc binding, injec-
tion noise and baseline drift (17). Approximately 1600
RU of the activator strand was immobilized using this
protocol.
Label-free SPR-based ribozyme cleavage assays
Full-length RNA was prepared as previously described
for the cis-blocking strategy without the addition of the
radiolabeled nucleotide. The Biacore X100 instrument was
equilibrated with the physiologically relevant reaction
buffer at 37C unless otherwise speciﬁed before all
ribozyme cleavage assays. The SPR baseline was stabilized
by performing 2–5 startup cycles, where each cycle
includes a capture and a regeneration step. The capture
step was performed by an injection of a total of 10–25 ng
transcribed cis-blocked RNA diluted in HBS-N buffer
over the reaction ﬂow cell (FC2) for 1min at a ﬂow rate
of 10 ml/min. The capture step typically yielded 50–300
RU of the SPR signal for the described constructs.
The regeneration step was performed by an injection of
25mM NaOH over both ﬂow cells for 30 sec at a ﬂow rate
of 30 ml/min.
Following the startup cycles, assay cycles were per-
formed. Each assay cycle includes a capture, a reaction
and a regeneration step. The capture and regeneration
steps in an assay cycle were performed as described for
those in the startup cycle. The reaction step was performed
by an injection of the running buffer containing 500mM
MgCl2 with or without 5mM theophylline over both FCs
for 5min at a ﬂow rate of 10 ml/min. Biacore sensorgram
processing and analysis were performed using Biacore X100
Evaluation Software v2.0 (Biacore). Due to the slight time
delay at which injected analyte reaches the respective ﬂow
cells, the resultant sharp spikes at the beginning and the end
of injection were excluded from the analysis (18). The pro-
cessed sensorgram (R) was ﬁt to a simple exponential
equation R=(R0 –R1) (ekdt)+R1, where R0 (ﬁt
globally for a given replicate) is the initial SPR signal
before the cleavage reaction, R1 (ﬁt locally for a given
replicate) is the residual response at the end of the
cleavage reaction and kd is the ﬁrst-order RNA dissociation
rate constant. Reported values are the mean of at least
three independent experiments.
RESULTS
A cis-acting RNA blocking sequence allows inhibition of
ribozyme cleavage during transcription
To prevent ribozyme constructs from cleaving during
transcription, we developed a new blocking method to
inhibit the formation of ribozyme-active conformations
co-transcriptionally. This blocking method was initially
demonstrated for the type III HHRz (with 50 and 30
termini in stem III) from sTRSV (Figure 2A). We ration-
ally designed a 12-nt RNA blocking sequence that is com-
plementary to part of the sTRSV HHRz transcript
(Figure 2B). The RNA blocking sequence was inserted
at the 50 end of the sTRSV HHRz transcript to generate
a cis-blocked sTRSV HHRz construct. As the RNA is
being synthesized, the blocking sequence is capable of
competitively hybridizing to the targeted ribozyme
sequence, thus preventing the transcribed RNA from
adopting a ribozyme-active conformation (Figure 2B).
A trans-acting DNA activator allows release of blocked
RNA through a strand-displacement reaction
To activate the blocked sTRSV HHRz RNA for subse-
quent cleavage assays, we rationally designed a 10-nt
RNA activation sequence as a single-stranded domain
directly attached to the 50 end of the RNA blocking
sequence (Figure 2B). The RNA activation sequence
serves as a toehold to allow for the design of a 21-nt
DNA activator complementary to the RNA activation
sequence and the ﬁrst 11 nt of the RNA blocking
sequence (Figure 2C). A toehold length between 5–10 nt
has been demonstrated to enhance the rate of
strand-displacement reactions by 106-fold (19). In this
way, the DNA activator can sequester the RNA
blocking sequence through a rapid toehold-mediated
strand-displacement reaction, thus allowing the RNA to
adopt the ribozyme-active conformation in the presence of
DNA activator for subsequent cleavage assays.
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Figure 2. Development of a cis-blocking and trans-activation strategy to generate functional continuous ribozyme-encoding RNA through in vitro
transcription reactions. (A) The cis-blocking strategy is illustrated on the sTRSV HHRz, and the arrow indicates the location of the cleavage site.
(B) A cis-blocking method can block the folding of a transcript into a ribozyme-active conformation. An RNA blocking sequence (red), comple-
mentary to part of the ribozyme (targeted ribozyme sequence, grey), is directly incorporated into the 50 end of the ribozyme-encoding transcript and
inhibits the ribozyme construct from folding into the active conformation during the transcription reaction. The activation sequence (yellow) provides
a toehold for the DNA activator strand, and the stabilizing sequence (black) can be modiﬁed to alter the length of the toehold and the stability of the
cis-blocked conformation. (C) A trans-activation method can redirect the folding of a cis-blocked transcript into a ribozyme-active conformation.
The cis-blocked ribozyme construct can be relieved by the addition of a DNA activator strand (brown), which competes with the targeted ribozyme
sequence for binding to the blocking sequence through a toehold-mediated strand-displacement reaction. As shown here, hybridization between the
ribozyme-encoding transcript and the DNA activator results in the transcript adopting the ribozyme-active conformation. All secondary structures
were predicted by RNAstructure folding software (32) and rendered using VARNA software (33).
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A RNA stabilizing sequence allows tuning of blocking
efﬁciency
We tuned the strength of the competitive hybridization
interaction between the RNA blocking and targeted
ribozyme sequences by introducing a stabilizing sequence
at the 30 end of the cis-blocked sTRSV HHRz construct
(Figure 2B). The stabilizing sequence is designed to hy-
bridize to the RNA activation sequence such that the
thermal stability of the blocked conformation can be
tuned by varying the length of the stabilizing sequence.
We increased the length of the stabilizing sequence from
4 to 14 nt in steps of 2 nt to generate a variety of
cis-blocked sTRSV HHRz constructs (Supplementary
Figure S1). The blocking efﬁciencies of the resultant
sTRSV HHRz variants were determined by quantifying
the fraction uncleaved RNA through PAGE analysis on
the transcription products (Figure 3A). By adding 2 nt to
the originally designed stabilizing sequence (sTRSV-2
HHRz construct), we increased the blocking efﬁciency
from 44% to 93%. These results support that the
cis-blocking method is efﬁcient in inhibiting ribozyme
cleavage during transcription.
We next incubated the cis-blocked sTRSV HHRz
variants at 5mM MgCl2, a concentration at which the
sTRSV HHRz is expected to undergo complete cleavage
within seconds (12). We observed no cleavage even after a
prolonged incubation time (1 h), indicating that the RNA
was incapable of spontaneously releasing itself from the
blocked conformation (Figure 3A). We then examined the
efﬁcacy of the toehold-mediated trans-activation strategy
by incubating the constructs at the same MgCl2 concen-
tration in the presence of the activator strand. The activa-
tion efﬁciencies of the cis-blocked constructs were
determined by quantifying the fraction cleaved of the
blocked RNA through PAGE analysis at the end of incu-
bation. By simple mixing of the cis-blocked constructs and
the activator strand without any denaturation and refold-
ing steps, we observed activation efﬁciencies up to 88%
of the blocked RNA (Figure 3A). The extent of cleavage
decreased as the toehold length decreased, and the data
indicate that the rate of the strand displacement reaction
may be too slow to allow effective activation of the
blocked RNA with toehold lengths between 0 and 2 nt.
These results highlight that our two-step cis-blocking
and trans-activation strategy can be tuned to efﬁciently
generate full-length functional RNA. The cis-blocked
sTRSV-2 HHRz construct was chosen for further charac-
terization owing to its high blocking and activation
efﬁciencies.
The cis-blocking mechanism provides a modular strategy
for inhibiting cleavage of various types of HHRzs
To examine the ﬂexibility of our two-step strategy, we
applied the cis-blocking and trans-activation methods to
the generation of functional continuous RNA for other
natural HHRzs. We initially tested the HHRz from the
peach latent mosaic viroid RNA (pLMVd), which exhibits
the same type III topology as the sTRSV HHRz (20)
(Supplementary Figure S2A). The RNA blocking, activa-
tion and DNA activator sequences designed for the
sTRSV HHRz were modiﬁed for complementarity to the
pLMVd HHRz sequence (Supplementary Figure S2B).
The blocking and activation efﬁciencies were assayed
under the same incubation conditions as for the
cis-blocked sTRSV HHRz constructs (Figure 3B). The
cis-blocked pLMVd HHRz RNA exhibited a blocking ef-
ﬁciency of 80% and an activation efﬁciency of 55%.
The observed ﬁnal fraction of cleaved cis-blocked pLMVd
HHRz RNA is in agreement with the previously reported
fraction of cleaved wild-type pLMVd HHRz measured at
the end of a cleavage reaction (21).
Next, we applied the two-step cis-blocking and
trans-activation strategy to HHRzs that exhibit the type I
topology (with 50 and 30 termini in stem I) (Supplementary
Figure S2A). We designed the RNA blocking sequences to
target the catalytic core region connecting stems I and II
of the HHRz encoded by the wild-type satellite DNA
of Schistosoma mansoni HHRzs (22) and an evolved
S. mansoni HHRz variant (Sma1-CG HHRz) that
exhibits improved cleavage kinetics (21) (Supplementary
Figure S2C and D). Stabilizing sequences were omitted
from these cis-blocked constructs, as the blocked conform-
ations were predicted to be relatively stable without them.
Both cis-blocked S. mansoni and Sma1-CG HHRz con-
structs exhibited high blocking efﬁciencies of 98% and
81%, respectively (Figure 3B). However, the activation
efﬁciency of the cis-blocked S. mansoni HHRz RNA
(24%) was signiﬁcantly lower than that of the cis-blocked
Sma1-CG HHRz RNA (78%) (Figure 3B). Relatively
poor cleavage activity of the S. mansoni HHRz has been
previously observed and attributed to inactive/alternate
RNA conformations (23). Improved cleavage activity has
been observed for this ribozyme when assays were per-
formed at different conditions (14,24). By varying the
MgCl2 concentration, incubation temperature and incuba-
tion time, we improved the activation efﬁciency of
the cis-blocked S. mansoni HHRz RNA from 24% to
74% (Supplementary Figure S3).
The sTRSV-blocking sequence provides a modular
strategy for inhibiting cleavage of sTRSV
ribozyme-based devices
The designed RNA blocking sequence for the sTRSV
HHRz targets a region within the ribozyme, and thus we
anticipate that the strategy developed for the sTRSVHHRz
can be directly applied to generate full-length RNA for
sTRSV HHRz-based devices (3,25). We inserted the RNA
blocking and activation sequences in a series of previously
characterized ribozyme devices composed of different
sensor, transmitter and actuator components to gener-
ate the corresponding cis-blocked L2b1, L2b5, L2b8,
L2b8-a1, L2b8-a14, L2b8-a1-t41, L2bOFF1 and L2b8tc
constructs (25) (Supplementary Figure S4). All synthetic
devices described here were designed to respond to theo-
phylline, except for the L2b8tc device, which was designed
to respond to tetracycline. The blocking and activation
efﬁciencies for all ribozyme devices were assayed
under the same conditions as for the cis-blocked sTRSV
HHRz RNA (Figure 3C). Blocking efﬁciencies of up
to 92% were obtained, supporting that the RNA
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blocking sequence is modular to constructs encoding
ligand-responsive ribozymes based on the same ribozyme
sequence. In contrast, performing transcription reactions
on these devices in the absence of the cis-blocking
sequence results in substantial cleavage of the ribozyme
device-encoding transcripts (Supplementary Figure S5).
The cis-blocked device transcripts were also incubated at
5mM MgCl2 in the absence and presence of the activator
strand for an hour at 25C (Figure 3C). Similar to the
results with the HHRz alone, the cis-blocked ribozyme
Figure 3. The cis-blocking and trans-activation strategy supports efﬁcient blocking and activation of diverse ribozyme-encoding transcripts. (A) The
toehold length tunes the efﬁciency of blocking and activation through the cis-blocking and trans-activation strategy applied to the wild-type sTRSV
HHRz. Cis-blocked sTRSV HHRz construct variants were incubated in the following: (i) HBS-EP buffer (10mM HEPES, 150mM NaCl, 3mM
EDTA, 0.05% P20, pH 7.4) (ﬁrst lane); (ii) HBS-N buffer (10mM HEPES, 150mM NaCl, pH 7.4) in the presence of 5mM MgCl2 for 1 h at 25
C
(second lane); and (iii) HBS-N buffer in the presence of 5mM MgCl2 and 10 mM activator for 1 h at 25C (third lane) (top panel). Denaturing PAGE
was used to separate the products from the transcription and cleavage reactions, where uncleaved and 30 cleaved fragments are shown. The fraction
RNA cleaved for each incubation condition was quantiﬁed by autoradiography (bottom panel). (B) The two-step cis-blocking and trans-activation
strategy can be applied to HHRz variants exhibiting diverse topologies and sequences. Cis-blocked constructs of the pLMVd HHRz, S.mansoni
HHRz and an evolved S. mansoni HHRz variant (Sma1-CG HHRz) were constructed and analysed in same manner as the sTRSV HHRz in
Figure 3A. (C) The two-step cis-blocking and trans-activation strategy can be directly applied to synthetic ribozyme devices. The blocking and
activation sequences designed for the sTRSV HHRz were directly incorporated into various synthetic ribozyme devices (L2b1, L2b5, L2b8, L2b8-a1,
L2b8-a14, L2b8-a1-t41, L2bOFF1, L2b8tc). The ribozyme device transcription products were analysed as described for the cis-blocked sTRSV
HHRz constructs in Figure 3A. A black vertical bar was used to denote samples run on different gels.
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device transcripts require the presence of both MgCl2 and
DNA activator to cleave. Activation efﬁciencies of up to
89% were obtained, supporting that the activator
sequence optimized for the sTRSV HHRz can also be
directly applied to the corresponding ribozyme devices.
Full-length RNA generated through the two-step, gel-free
strategy exhibit similar cleavage rate constants to RNA
generated through trans-blocking, gel-puriﬁed methods
We next examined the cleavage rate constants (k)
measured for the functional continuous RNA generated
through the two-step cis-blocking and trans-activation
strategy. Gel-based cleavage assays were performed on
radiolabeled transcripts at physiologically relevant
reaction conditions [500 mM MgCl2, 100mM NaCl,
50mM Tris-HCl (pH 7.5)] at 37C (Supplementary
Figure S6). The cis-blocked RNA was activated by incu-
bation with the DNA activator strand for 1 min before the
addition of MgCl2. The cleavage rate constants were
obtained for the cis-blocked sTRSV-2 HHRz (4.0,
3.0min1), L2b8-14 (1.06, 0.33min1), L2b8-a1 (0.351,
0.043min1), L2b8-a1-t41 (0.186, 0.028min1) and L2b8
(0.063, 0.008min1) constructs in the absence and
presence of 5mM theophylline, respectively (Figure 4A).
The cleavage rate constants measured for the cis-blocked
sTRSV HHRz construct were comparable in the absence
and presence of theophylline, indicating that theophylline
has no non-speciﬁc effect on the cleavage activity. On the
other hand, the cleavage rate constants measured for the
synthetic ribozyme devices in the presence of theophylline
were slower than those measured in the absence of theo-
phylline, indicating that theophylline binding to the
aptamer shifts the distribution between the two functional
conformations to the ribozyme-inactive state and thus
results in a slower cleavage activity as expected. We
compared these rate constants with those previously
obtained through the traditional trans-blocking strategy,
which requires PAGE puriﬁcation to recover the blocked
full-length RNA strands (25) (Figure 4B). The measured
cleavage rate constants through the two different
ribozyme-encoding RNA generation strategies exhibit a
strong linear correlation [Pearson product moment
(r): 0.985] with a slope of 0.82. These results validate
that the cis-blocking and trans-activation mechanisms
used in our strategy have little impact on the measured
ribozyme cleavage kinetics.
A label-free, continuous, SPR-based assay to support
rapid monitoring of ribozyme cleavage
Our two-step cis-blocking and trans-activation strategy
allows the development of a label-free, continuous
cleavage assay based on the Biacore sensor platform
(Figure 5). We generated a reaction sensor surface by co-
valently linking the DNA activator strand to the sensor
surface (Figure 5A). The reaction sensor surface then
allows both the capture and activation of the cis-blocked
RNA through the programmed hybridization interaction
(Figure 5B). The capture of RNA is monitored in real time
and represented as an increase in the SPR signal owing to
increased mass density near the sensor surface. The
cleavage reaction is initiated by the injection of a buffer
containing MgCl2 across the ﬂow cell surface (Figure 5C).
Cleavage of the RNA results in a 30 cleaved fragment that is
weakly hybridized to the immobilized DNA activator
strand through ﬁve bases, and the 30 cleaved fragment dis-
sociation rate constant can be predicted by a previously
developed secondary structure nearest neighbor analysis
(23) (Supplementary Figure S7). The predicted dissociation
Figure 4. The two-step cis-blocking and trans-activation strategy does not impact the cleavage rate constants of the resulting ribozyme constructs.
(A) In vitro ribozyme cleavage rate constants on full-length RNA generated from the cis-blocking strategy. Gel-based cleavage assays were performed
on the cis-blocked sTRSV HHRz, L2b8, L2b8-a1, L2b8-a14 and L2b8-a1-t41 constructs at 37C in 500mM MgCl2, 100mM NaCl, 50mM Tris-HCl
(pH 7.5). Cleavage rate constants (k) and errors are reported as the mean and standard deviation from at least three independent assays.
(B) Correlation analysis of cleavage rate constants of full-length RNA generated from the two ribozyme-encoding RNA generation strategies
indicates a strong correlation between these two cleavage rate constants; Pearson correlation coefﬁcient (r): 0.985, slope: 0.821±0.05. The
cleavage rate constants in the absence and presence of 5mM theophylline for the sTRSV HHRz (4.3, 4.3min1), L2b8-a14 (1.4, 0.33min1),
L2b8-a1 (0.7, 0.1min1), L2b8-a1-t41 (0.16, 0.096min1) and L2b8 (0.14, 0.025min1) constructs were previously determined with the trans-blocking
strategy under the same reaction conditions (25).
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rate constant is several orders ofmagnitude greater than the
cleavage rate constant measured for the fastest cleaving
construct in this study. Therefore, upon cleavage, the 30
cleaved fragment will rapidly dissociate from the 50
cleaved fragment-DNA activator duplex, resulting in a
decrease in the SPR signal owing to decreased mass
density near the sensor surface. The rate of SPR signal
decrease, which reﬂects how fast the ribozyme construct
cleaves, is ﬁtted to a ﬁrst-order exponential decay
equation to obtain the RNA dissociation rate constant.
During the assay, both full-length and 50 cleaved fragments
can also spontaneously dissociate, although slowly, from
the activator strands and contribute to the observed
decrease in SPR signal. Thus, the measured RNA dissoci-
ation rate constant is a lump sum of dissociation rate
constants due to irreversible cleavage and reversible hybrid-
ization reactions. Lastly, because the DNA-based reaction
sensor surface is highly stable, the surface can be
regenerated, by an injection of nucleic acid denaturants
(i.e. NaOH) to remove residual RNA, and reused for sub-
sequent cleavage assays (Figure 5D).
The SPR-based RNA dissociation rate constants reﬂect
the gel-based cleavage rate constants
The SPR-based cleavage assay was applied to monitor the
cleavage of a set of cis-blocked ribozyme constructs under
reaction conditions similar to the gel-based cleavage assay
conditions. The cis-blocked sTRSV-2 HHRz and a series
of cis-blocked ribozyme device (L2b8, L2b8-a1, L2b8-a14
and L2b8-a1-t41) transcripts were captured on the
chip surface through the DNA activator. Cleavage reac-
tions were subsequently initiated by injecting buffer
[100 mM NaCl, 50mM Tris-HCl (pH 8.5)] containing
either (i) no MgCl2; (ii) 500 mM MgCl2; or (iii) 500 mM
MgCl2 and 5mM theophylline (Figure 6A; Supplementary
Figure S8). RNA dissociation rate constants were deter-
mined by ﬁtting the resulting Biacore sensorgrams to a
simple exponential equation.
Activator
A
Blocked RNA
Sensor Surface
B
Biacore Sensorgram
RU
t
2+
Activated RNA
Cleaved RNA
C
Mg
RU
t
D
NaOH RU
t
Figure 5. Schematic of the SPR-based ribozyme cleavage assay. (A) A sensor surface for ribozyme cleavage characterization is generated by
conjugating the DNA activator strand directly to the chip surface. (B) The cis-blocked ribozyme-encoding transcript is injected over the
activator-coated surface, and the hybridization interaction between the transcript and the activator strand results in an increase in SPR signal,
represented by RU. The hybridization of the ribozyme construct to the activator-coated surface results in the RNA adopting the ribozyme-active
conformation. (C) The cleavage reaction is initiated by the injection of buffer containing MgCl2 over the sensor surface. Ribozyme cleavage results in
a quick dissociation of the 30 cleaved fragment, resulting in a decrease in SPR signal. The RNA dissociation rate constant is obtained by ﬁtting the
injection portion of the sensorgram to a ﬁrst-order exponential decay equation (see Materials and Methods). (D) Finally, the surface is regenerated
for the next assay by an injection of 25mM NaOH to remove residual RNA.
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The RNA dissociation rate constants due to ribozyme-
independent spontaneous dissociation from the DNA ac-
tivator are determined at reaction condition (i), as the
ribozyme constructs are expected to exhibit little catalytic
activity in the absence of MgCl2 (26). The measured RNA
dissociation rate constants at this condition range from
0.03 to 0.21min1, suggesting that the reversible hybrid-
ization reaction exhibits a slow dissociation rate constant
(Supplementary Figure S8). We next examined the RNA
dissociation rate constants obtained under reaction
conditions (ii) and (iii) (Figure 6B). For all theophylline-
responsive ribozyme devices, the measured RNA dissoci-
ation rates in the presence of 5mM theophylline are lower
than the respective rates measured in the absence of theo-
phylline, identical to the trend observed for the gel-based
cleavage rate constants (Figure 4A). Theophylline binding
to the aptamer component within the device is expected
to result in no detectable change in SPR signal due to
the low density of RNA being captured on the surface.
In addition, the measured dissociation rate constants for
the cis-blocked sTRSV-2 HHRz RNA are similar in the
presence and absence of theophylline (1.9 and 2.2min1,
respectively), indicating that theophylline has little non-
speciﬁc effect on the measured dissociation rate constants
on the Biacore. We further characterized the dissociation
rate constants of two of the ribozyme devices under differ-
ent pH and magnesium ion concentrations and observed
similar trends as expected from previous kinetics studies
on the sTRSV HHRz (22,24,27–29) (Supplementary
Figure S9).
Finally, we performed a ranking correlation analysis by
comparing the cis-blocked ribozyme SPR-based RNA dis-
sociation rate constants to the corresponding gel-based
cleavage rate constants. The rate constants obtained
through the two different characterization methods show
a signiﬁcant statistical dependence, with a high Spearman
(rank) correlation coefﬁcient (r=0.964) (Figure 6C).
These results support that the SPR-based RNA
dissociation rate constant reﬂects the ribozyme cleavage
rate constant. However, the dissociation rate constants
determined by the SPR-based assay become less reﬂective
of the cleavage activities when characterizing ribozyme
constructs that exhibit slow cleavage kinetics. For
example, the RNA dissociation rate constant for the
L2b8 construct in the presence of theophylline, which
exhibits the slowest cleavage rate constant (0.15min1)
among the ribozyme constructs characterized, is compar-
able with that in the absence of MgCl2 (0.08min
1), sug-
gesting that the measured rate constant is largely
contributed to by the cleavage-independent dissociation
reaction.
DISCUSSION
We developed an efﬁcient two-step ribozyme blocking and
activation strategy that supports scalable generation
of functional continuous transcripts encoding ribozyme
constructs through in vitro transcription reactions. Our
strategy is inspired by the natural cis-blocking mechanism
used by the HDV ribozyme (16). We developed a similar
cis-blocking method by designing a synthetic RNA
blocking sequence complementary to the 30 end of the
HHRz to prevent the formation of the active HHRz struc-
ture during transcription. We demonstrated a tuning
strategy based on stabilizing the blocked HHRz conform-
ation to increase blocking efﬁciency. As our strategy
depends on the addition of independent blocking
sequences ﬂanking the ribozyme sequence, these added
sequences can be readily altered to work with a variety
of different ribozyme sequences and architectures. The
adaptability and broad utility of our strategy was
demonstrated on additional type I and type III HHRzs
and a wide array of synthetic ribozyme devices.
Previous kinetic studies demonstrated that 50% of the
full-length RNA generated by the trans-blocking strategy
remains uncleaved (8). We speculate that the use of a
Figure 6. The SPR-based RNA dissociation rate constants are correlated to the corresponding gel-based cleavage rate constants. The SPR-based
assays were performed on the cis-blocked sTRSV HHRz, L2b8, L2b8-a1, L2b8-a14 and L2b8-a1-t41 constructs at 37C with buffer [100 mM NaCl,
50mM Tris-HCl (pH 8.5)] containing the following: (i) 500mM MgCl2, (ii) 500 mM MgCl2 and 5mM theophylline. (A) The projected dissociation
kinetics are generated from the single-exponential equation, R=(R0 – R1) (ekdt)+R1, setting the SPR signal before the start of reaction (R0)
and residual response at the end of the cleavage reaction (R1) to 1 and 0, respectively, and kd to the experimentally determined value for each RNA
device. Solid lines: 0mM theophylline; dashed lines: 5mM theophylline. (B) RNA dissociation rate constants (kd) and errors are reported as the
mean and standard deviation from at least three independent assays. (C) Correlation analysis of observed RNA dissociation rate constants and
corresponding ribozyme cleavage rate constants indicates a strong correlation between these two rate constants [Spearman (rank) correlation
coefﬁcient (r): 0.964].
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denaturing PAGE puriﬁcation step for the recovery of
full-length transcription products, which requires an add-
itional RNA refolding step, may render the trans-blocking
method more prone to misfolding and therefore result
in signiﬁcant amounts of inactive transcription products.
We used a trans-activation method based on a toehold-
mediated strand-displacement mechanism, which offers
the advantage of bypassing the need of additional RNA
denaturation and refolding steps, thus providing a rapid
two-step process (co-transcriptional blocking and activa-
tion) to yield large quantities of functional continuous
RNA without the need of laborious PAGE puriﬁcation
processes. Kinetic assays demonstrated that the in vitro
cleavage rate constants measured for ribozymes generated
through our two-step cis-blocking and trans-activation
strategy were similar to those rate constants measured
for identical ribozymes generated through the more trad-
itional trans-blocking and gel puriﬁcation method, sup-
porting that our strategy minimally impacts the resulting
ribozyme cleavage kinetics. This is in contrast to a trans-
activation method previously used in the development
of allosteric HHRz targeted ribozyme-attenuated probes
(TRAP) (10), in which an attenuation probe was
appended to the 30 end of the enzyme strand of a discon-
tinuous HHRz and designed to anneal to the catalytic
core, thus inhibiting cleavage of the substrate strand.
The blocked HHRz was released by denaturing and re-
folding the enzyme and substrate strands with an antisense
strand designed to sequester the attenuation probe. Slower
measured cleavage rate constants were observed for the
activated TRAP system, suggesting that the hybridization
reaction between the antisense strand and attenuation
probe is kinetically limited.
Our strategy uses a trans-acting DNA strand to activate
the blocked RNA, supporting the development of a novel
cleavage assay based on SPR. Our SPR-based assay offers
several unique advantages over the more traditional
gel-based assay, in that it allows label-free, real-time and
continuous monitoring of ribozyme cleavage. In addition,
the SPR instrument requires little material due to a
microﬂuidics-based ﬂow system and is highly automatable
to support scalable characterization of many different
ribozyme constructs. The SPR-based cleavage assay was
applied to measure the rate constant of SPR signal
decrease for a set of ribozyme-encoding transcripts
under physiologically relevant conditions. The results of
a rank correlation analysis support that the measured
RNA dissociation rate constants from our SPR-based
assays reﬂect the ribozyme cleavage rate constants
obtained from the gel-based assays. However, there is an
inherent limitation in the SPR assay, which is based on
linking a chemical reaction step to a product dissociation
event. Under certain reaction conditions (e.g. high Mg
concentrations at which ribozymes exhibit high cleavage
activity) the product dissociation may become the
rate-limiting step. In this case, the measured RNA dissoci-
ation rate constant will be largely determined by the
product dissociation rate constant and thus provides
little information on the actual ribozyme cleavage activity.
Another limitation in our current assay design is that
the measured RNA dissociation rate constant is
contributed to by both the cleavage-dependent dissoci-
ation rate constant (30 cleaved fragment from the 50
cleaved fragment-immobilized DNA activator hybrid)
and cleavage-independent dissociation rate constant (50
cleaved and full-length fragments from the immobilized
DNA activator). In the case of constructs that exhibit a
slow chemical step (with a rate constant comparable with
that of the cleavage-independent dissociation step), the
measured RNA dissociation rate constant can be signiﬁ-
cantly contributed to by the cleavage-independent dissoci-
ation rate constant. In other words, the measured RNA
dissociation rate will reﬂect the chemical step less and thus
provide little information on ribozyme cleavage activity.
In addition, the format of any SPR-based assay requires
continuous injection of analytes, which presents limita-
tions for the characterization of ribozyme constructs ex-
hibiting low cleavage activities (and thus requiring longer
injection times). To address these limitations, efforts can
be directed toward enhancing the stability of the hybrid-
ization reaction between the ribozyme-encoding RNA and
the DNA activator. For example, the length of the RNA
activation sequence can be extended or alternative back-
bones for the activator strand, such as peptide nucleic
acid, can be used that will result in more stable duplexes
with the RNA transcript (30). As an additional approach,
the range of cleavage activities that can be analysed
through the SPR-based assays may be extended by using
instrument platforms that support analysis over longer
reaction times. For example, an instrument can be set
up to inject analyte directly through the running buffer
syringe or the instrument can be modiﬁed with an
external peristaltic pump (31). With further development,
our SPR-based cleavage assay will offer a powerful
strategy for rapid, quantitative characterization of a
wide variety of ribozyme constructs.
Recent advances in RNA engineering have successfully
coupled ribozymes to various natural and synthetic sensor
components to construct gene-regulatory devices that
function in diverse genetic systems (3–6). We have previ-
ously demonstrated that the in vitro cleavage rate con-
stants and in vivo gene-regulatory activities of these
ribozyme-based devices are closely correlated (25). In
addition, recent computational models have highlighted
the direct and multi-faceted impact that cleavage rate con-
stants can have on the in vivo gene-regulatory performance
of this class of genetic devices, supporting this property as
a key engineering parameter to target for device optimiza-
tion (7). Therefore, enabling tools that support rapid and
scalable functional characterization of ribozyme con-
structs will advance our ability to characterize key
properties of these genetic devices (e.g. in vitro cleavage
rate constants) and thus guide the design of new
ribozyme-based devices with improved gene-regulatory
activities. The described two-step ribozyme cis-blocking
and trans-activation strategy provides an efﬁcient,
scalable method for generating continuous ribozyme-
encoding transcripts for further downstream characteriza-
tion. This approach is fully complemented by the rapid,
label-free and real-time SPR-based cleavage assay, which
directly integrates the trans-activation strategy with the
recruitment step to the chip surface. Together, these
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methods describe a streamlined, solution-based strategy
for ribozyme device characterization that will support
the design, optimization and probing of this important
class of regulatory molecules.
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